NCT02724345View on ClinicalTrials.gov

Postoperative Adjuvant TACE Treatment in CK18 Positive Patients

CompletedOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2015

Conditions
Postoperative Adjuvant TACEHepatocellular Carcinoma.
Trial Locations (1)

200438

Eastern hepatobilliary surgery hospital, Shanghai

All Listed Sponsors
lead

Eastern Hepatobiliary Surgery Hospital

OTHER

NCT02724345 - Postoperative Adjuvant TACE Treatment in CK18 Positive Patients | Biotech Hunter | Biotech Hunter